A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality ...
Tag: transarterial
-
Null results research now published by major behavioral medicine journal
-
How drugs can target the thick “scar tissue” of pancreatic cancer
-
‘Shocking’ discovery: Electricity from electric eels may transfer genetic material to nearby animals
-
Study identifies key ingredient for affordable fuel cell catalysts
-
Meteorites likely source of nitrogen for early Earth
-
Pivotal moment for humanity as tipping point threats and opportunities accelerate